Evidence map›Paper›PMID 24154493›Full record

ArticleScientific reports2013

Ultrabright and multicolorful fluorescence of amphiphilic polyethyleneimine polymer dots for efficiently combined imaging and therapy.

Yun Sun, Weipeng Cao, Shengliang Li, Shubin Jin, Kelei Hu, Liming Hu, Yuanyu Huang, Xueyun Gao, Yan Wu, Xing-Jie Liang

Abstract read
In one paragraph

Article in Scientific reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yun Sun1] Chinese Academy of Sciences Key Lab for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology No.11, First North Road, Zhongguancun, Beijing 100190, P.R. China [2] College of Life Science and Bioengineering Beijing University of Technology No.100 Pingleyuan, Chaoyang District, Beijing 100124, P.R.China [3].
Weipeng Cao
Shengliang Li
Shubin Jin
Kelei Hu
Liming Hu
Yuanyu Huang
Xueyun Gao
Yan Wu
Xing-Jie Liang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multifunctional nanoparticles as theranostic tools hold great potential for its unique and efficient way to visualize the process of disease treatment. However, the toxicity of conventional fluorescent labels and difficulty of functionalization limit their widespread use. Recently, a number of amino-rich polymers have demonstrated high luminescent fluorescence but rarely showed potential for in vivo imaging due to their blue fluorescence. Here, a general route has been found to construct polymer-based multifunctional nanoparticles for combined imaging and drug delivering. The weak fluorescent polyethyleneimine (PEI) has been conjugated with hydrophobic polylactide as the amphiphilic PEI for construction of nanoparticles which showed bright and multicolor fluorescence with high drug loading capacity. The paclitaxel-loaded nanoparticles showed significant therapy effect in contrast to the free paclitaxel. Meanwhile, fluorescence imaging of the nanoparticles showed accumulation around tumor. These results demonstrate a new type of polymer-based multifunctional nanoparticles for imaging-guided drug delivery.

Indexed as

Drug CarriersDrug Delivery SystemsOptical ImagingAnimalsAntineoplastic Agents, PhytogenicCell Line, TumorDiagnostic ImagingFemaleHeterograftsHumansHydrophobic and Hydrophilic InteractionsMaterials TestingMiceMolecular ImagingNeoplasmsPaclitaxelAntineoplastic Agents, PhytogenicDrug CarriersPaclitaxelPolyestersPolyethyleneiminepoly(lactide)PolymersSurface-Active Agents

Identifiers

PMID24154493
PMCPMC3807111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.